C. Bouchet

494 total citations
16 papers, 403 citations indexed

About

C. Bouchet is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, C. Bouchet has authored 16 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 5 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in C. Bouchet's work include Protease and Inhibitor Mechanisms (8 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and HER2/EGFR in Cancer Research (3 papers). C. Bouchet is often cited by papers focused on Protease and Inhibitor Mechanisms (8 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and HER2/EGFR in Cancer Research (3 papers). C. Bouchet collaborates with scholars based in France. C. Bouchet's co-authors include K. Hacène, J Oglobine, Antonio Gentile, F. Spyratos, M. Tubiana-Hulin, Véronique Becette, F. Spyratos, M. Ferrero-Poüs, V Le Doussal and Frédérique Spyratos and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Breast Cancer Research and Treatment.

In The Last Decade

C. Bouchet

14 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Bouchet France 9 309 202 127 116 87 16 403
J Geurts-Moespot Netherlands 7 219 0.7× 168 0.8× 142 1.1× 60 0.5× 38 0.4× 9 330
J Oglobine France 9 259 0.8× 140 0.7× 92 0.7× 111 1.0× 82 0.9× 13 328
F. Spyratos France 8 206 0.7× 223 1.1× 110 0.9× 55 0.5× 52 0.6× 25 391
M.J. Duffy Ireland 7 172 0.6× 178 0.9× 103 0.8× 66 0.6× 35 0.4× 7 298
Peter Hamer United States 12 208 0.7× 226 1.1× 189 1.5× 38 0.3× 28 0.3× 22 457
Garth L. Nicolson United States 8 121 0.4× 151 0.7× 180 1.4× 91 0.8× 25 0.3× 9 338
Selvi Palaniappan United States 6 314 1.0× 100 0.5× 96 0.8× 93 0.8× 191 2.2× 9 453
Mehdi El Hour Belgium 5 127 0.4× 127 0.6× 174 1.4× 83 0.7× 46 0.5× 5 345
Aaron Sabbota United States 7 188 0.6× 260 1.3× 155 1.2× 48 0.4× 44 0.5× 11 424
Kelly Yan United States 2 122 0.4× 71 0.4× 163 1.3× 76 0.7× 147 1.7× 3 385

Countries citing papers authored by C. Bouchet

Since Specialization
Citations

This map shows the geographic impact of C. Bouchet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Bouchet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Bouchet more than expected).

Fields of papers citing papers by C. Bouchet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Bouchet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Bouchet. The network helps show where C. Bouchet may publish in the future.

Co-authorship network of co-authors of C. Bouchet

This figure shows the co-authorship network connecting the top 25 collaborators of C. Bouchet. A scholar is included among the top collaborators of C. Bouchet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Bouchet. C. Bouchet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Mimoun, G., Salomon Y. Cohen, Typhaine Grenet, et al.. (2016). Traitement par ranibizumab des néovascularisations choroïdiennes secondaires à un pseudoxanthome élastique : résultats de l’étude observationnelle française PiXEL. Journal Français d Ophtalmologie. 39(4). 370–375. 8 indexed citations
3.
Bouchet, C., Martine Antoine, Catherine Genestie, et al.. (2005). L'évaluation conjointe du contenu en ADN et de la fraction de cellules en phase S est un paramètre pronostique indépendant dans les cancers du sein de stades I et II. Cancer/Radiothérapie. 9(8). 575–586. 2 indexed citations
4.
5.
Bouchet, C., et al.. (2003). Limited prognostic value of c-erbB-2 compared to uPA and PAI-1 in primary breast carcinoma. The International Journal of Biological Markers. 18(3). 207–217. 10 indexed citations
6.
Spyratos, Frédérique, C. Bouchet, Sengül Tozlu, et al.. (2003). Prognostic value of uPA, PAI-1 and PAI-2 mRNA expression in primary breast cancer.. PubMed. 22(5). 2997–3003. 24 indexed citations
7.
Bouchet, C., M. Ferrero-Poüs, K. Hacène, Véronique Becette, & F. Spyratos. (2003). Limited Prognostic Value of c-erbB-2 Compared to uPA and PAI-1 in Primary Breast Carcinoma. The International Journal of Biological Markers. 18(3). 207–217. 7 indexed citations
8.
Ferrero-Poüs, M., K. Hacène, C. Bouchet, et al.. (2000). Relationship between c-erbB-2 and other tumor characteristics in breast cancer prognosis.. PubMed. 6(12). 4745–54. 65 indexed citations
9.
Bouchet, C., K. Hacène, Patrick Martin, et al.. (2000). [Breast cancer: prognostic value of a dissemination index based on 4 components of the urokinase-type plasminogen activator system].. PubMed. 48(9). 825–31. 2 indexed citations
10.
Bouchet, C., K. Hacène, Pierre‐Marie Martin, et al.. (1999). Dissemination Risk Index Based on Plasminogen Activator System Components in Primary Breast Cancer. Journal of Clinical Oncology. 17(10). 3048–3057. 58 indexed citations
11.
Bouchet, C., et al.. (1998). Prognostic value of urokinase plasminogen activator in primary breast carcinoma: comparison of two immunoassay methods. British Journal of Cancer. 77(9). 1495–1501. 14 indexed citations
12.
Romain, S, et al.. (1995). Comparative study of four extraction procedures for urokinase type plasminogen activator and plasminogen activator inhibitor-1 in breast cancer tissues.. PubMed. 33(9). 603–8. 8 indexed citations
13.
Bouchet, C., et al.. (1994). Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas. British Journal of Cancer. 69(2). 398–405. 137 indexed citations
14.
Bouchet, C., et al.. (1994). [Prognostic value of urokinase-type plasminogen activator and 2 inhibitors PAI-1 and PAI-2 in breast cancer].. PubMed. 81(9). 770–9. 4 indexed citations
15.
Bouchet, C., K. Hacène, N Pourreau-Schneider, et al.. (1991). Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours. British Journal of Cancer. 64(5). 926–932. 42 indexed citations
16.
Dufer, Jean, et al.. (1982). [Changes in the immune status as a function of age and the appearance of spontaneous mammary tumors in C3H/Bi mice].. PubMed. 69(2). 143–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Geurts-Moespot Breakdown of academic impact, for papers by J Oglobine Breakdown of academic impact, for papers by F. Spyratos Breakdown of academic impact, for papers by M.J. Duffy Breakdown of academic impact, for papers by Peter Hamer Breakdown of academic impact, for papers by Garth L. Nicolson Breakdown of academic impact, for papers by Selvi Palaniappan Breakdown of academic impact, for papers by Mehdi El Hour Breakdown of academic impact, for papers by Aaron Sabbota Breakdown of academic impact, for papers by Kelly Yan
Rankless by CCL
2026